Retinal degeneration represents a primary cause of irreversible blindness, with both its onset and severity differing significantly among various conditions.
Read more
Striatech, a leader in preclinical vision research devices and tools, has unveiled its New Non-Aversive Animal Platform for the OptoDrum
Read more
A groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
Read more
Cutting-edge CacoReady Cell-based Plates with pre-developed Caco-2 cells for in vitro permeability assessment have been a key tool in a
Read more
Choosing the most appropriate well system format, whether it’s a transwell, non-transwell, or individual transwell, can drastically affect the outcome
Read more
The unique rapid plasma protein binding assay for sticky and tightly bound compounds can be used with plasma from any
Read more
The Ksander Lab at Boston’s Schepens Eye Research Institute has unveiled valuable insights into the role of subretinal microglia in
Read more
Millions of individuals worldwide are affected by vision loss caused by retinal degenerative diseases, such as retinitis pigmentosa (RP) and
Read more
In vitro mammalian cells such as Caco-2 or MDCKII, crucial for preclinical research and drug discovery, are highly challenging to
Read more
Plasma protein binding is a phenomenon where drugs bind to proteins in the blood, thereby reducing the concentration of free,
Read more